Refine by
Heart Failure Explored On New Episode Of The Heart Failure Services
22 services found
by:Genome Biologics based inFrankfurt am Main, GERMANY
HFrEF occurs when the left ventricular ejection fraction (LVEF) is 40% or less and is accompanied by progressive left ventricular dilatation and adverse cardiac remodelling. Worldwide, the burden of heart failure has increased to an estimated 23 million people, and approximately 50% of cases are HF-rEF. Despite several therapeutic options, heart failure with reduced ejection fraction remains a ...
by:ReportLinker based inLyon, FRANCE
Life insurance represents the leading market segment with almost 58% of the overall market in terms of value. The EU represents just over 35% of the overall global insurance market. Developed markets dominate the global insurance industry (one of the most profitable financial services), with the US, the UK, Germany, France and Japan holding the largest combined share, reports Global Industry ...
Manufactured by:Donisi Health based inTel Aviv - Jaffa, ISRAEL
Donisi’s solution?detects a wide array of physiological?and stress?indicators including those key for detecting heart failure exacerbations. Through our unique AI-driven alert system, users and their support team are provided easy to understand notifications. ...
by:Genome Biologics based inFrankfurt am Main, GERMANY
Loss of cardiomyocytes (heart cells) is the primary hallmark of heart failure. However, unlike other cell types, there is a limited capacity for cardiomyocytes proliferation in the adult heart and in the failing human heart. Therefore, regenerative approaches to replenish the lost cardiomyocytes are necessary to recover the contractile capacity of the heart and prevent death. Targeting ...
Manufactured by:SynCardia Systems, LLC, based in, ARIZONA (USA)
SynCardia Total Artificial Heart (TAH) patients are effectively heart transplant recipients with four mechanical valves. They have a near-normal CVP, normal physiology and the source of their heart failure has been eliminated through biventricular replacement. In addition, there are no inotropes or anti-rejection medications needed. TAH patients benefit from high cardiac output, typically 7 L/min ...
Manufactured by:Creative Biogene based inShirley, NEW YORK (USA)
Creative Biogene has long-standing experience in conducting preclinical zebrafish model studies of cardiovascular disease. We offer consultancy and preclinical zebrafish models of cardiovascular disease including hypertension, arrhythmia, heart failure and atherosclerosis, etc. Similar to other animal models, wild-type zebrafish do not spontaneously develop cardiovascular diseases mimicking the ...
by:LumiraDx UK Limited based inLondon, UNITED KINGDOM
People living with long-term conditions can play a significant role in managing and improving their own ...
Manufactured by:Jarvik Heart, Inc. based inNew York, NEW YORK (USA)
The Jarvik 2000® is designed to provide reliable support to the ailing heart for a decade or longer. Accelerated tests of the pump’s bearings show that there is so little wear that the bearings will last decades, so many more years of real-time testing are required to know whether or not the pump will achieve or exceed this challenging design objective. Presently, our longest-sustained ...
Manufactured by:BiVACOR, Inc. based inHouston, TEXAS (USA)
Implantation of a TAH is a treatment option for patients with end-stage HF who need support while on a heart transplant waiting list or who do not qualify for a transplant. Removal of the native ventricles allows the device to completely replace the function of the native ...
by:Medixine based inEspoo, AUSTRALIA
Integrated care is a ‘mega-shift’ driving major change at a health-system level and is impacting the design of care delivery services globally. Research (Kings Fund) indicates that best practice integrated care programs can substantially reduce emergency department admissions and decrease costs for patients with complex chronic conditions and who are frequent users of hospital ...
Manufactured by:NaviGate Cardiac Structures, Inc., (NCSI) based inLake Forest, CALIFORNIA (USA)
Tricuspid Valve insufficiency (regurgitation) is a medical condition where the valve between the right ventricle (pumping chamber) and the right atrium does not close properly. This allows blood to reverse instead of moving towards the pulmonary artery for reoxygenation in the lungs. As this condition worsens, blood is backed up and creates edema of the lower extremities, damage to ...
by:V-Wave Ltd. based inCaesarea Industrial Park (N), ISRAEL
Heart failure (HF) is a condition where the heart is not pumping enough blood to meet the needs of the body. When heart failure occurs, there is an increase in pressure in the heart and lungs, plus fluid build-up in the lungs. The fluid causes congestion and makes it hard to breathe during activities or even when at ...
by:Nanowear, Inc. based inBrooklyn, NEW YORK (USA)
Nanotechnology enabled sensors changing at home diagnostics. Technological advances in the healthcare and medical devices industry have led to an increase in the demand for compact and portable diagnostic sensing systems that can read and transmit medical-grade vital statistics accurately and quickly from the human body. The primary factors that drive the application of nanosensors in healthcare ...
Manufactured by:AnaBios Corporation based inSan Diego, CALIFORNIA (USA)
EX VIVO Human Platforms for Cardiovascular Drug Discovery. Broadly defined, cardiovascular disease is the leading cause of death for men and women across most racial and ethnic groups in the United States with one person dying approximately every 34 seconds1. To drive successful clinical translation of new cardiovascular medicine, AnaBios develops relevant human ex vivo platforms for many ...
Manufactured by:AnaBios Corporation based inSan Diego, CALIFORNIA (USA)
CardioPRIME® is the AnaBios approach for measuring human cardiomyocyte functionality and sets the industry standard for cardiac-based biomedical research. By leveraging the robust excitation-contraction coupling of mature primary human cardiomyocytes and direct measurements of sarcomeric length, CardioPRIME offers unprecedented insight into cardiomyocyte functionality and provides ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
Mesoblast has a strong and extensive global intellectual property (IP) portfolio with protection extending through to at least 2040 in all major markets. This IP position is expected to provide the Company with substantial commercial advantages as it develops its product candidates for major markets including the United States, Europe, Japan and ...
by:ForeSee Medical, Inc. based inSan Diego, CALIFORNIA (USA)
Medicare risk adjustment is a process that Medicare uses to pay health plans. Medicare pays health plans based on the number of Medicare beneficiaries enrolled in the plan, and the risk scores of those beneficiaries. Medicare risk scores are calculated using a formula that takes into account many different factors, including age, sex, race, health status, and use of Medicare services. Medicare ...
by:ICON plc based inDublin, IRELAND
ICON's cardiovascular trial experience, supported by a global team of experts. ICON has extensive experience in cardiovascular clinical research trials across the entire drug development spectrum. There is still significant unmet need within select cardiovascular/metabolic (CVM) disorders. Unfortunately, the cost of developing drugs and devices in this area has been rising steadily. ICON, a full ...
Manufactured by:ScottCare Cardiovascular Solutions based inCleveland, OHIO (USA)
Ambucor is the proven INSOURCED labor and technology service for 24/7 Ambulatory ECG and CIED Remote Monitoring that optimizes compliance while maximizing value. We combine our 24-hour ECG monitoring software technology with the human element. For the patient, this means a better experience through personal assistance. For the physician, this means increased compliance, greater ...
Manufactured by:InvivoSciences, Inc. (IVS) based inMadison, WISCONSIN (USA)
Human engineered tissue (EHT)-based high content analysis can be applied to drug discovery projects at their compound screening and lead optimization stage. Mass-produced human engineered tissues will recapitulate physiological functions of native tissues in micro tissues growing in 96-well plates or 384-well plates (coming soon). Patient-derived cells can also be used to fabricate engineered ...